Glenmark to pay $29.6M to settle multistate lawsuit
Settlement resolves allegations of collusion to fix generic drug prices and includes money for customer claims.
Global drug manufacturer Glenmark Pharmaceuticals has agreed to pay $29.6 million to settle a lawsuit filed by dozens of states.